Rights and permissions
About this article
Cite this article
Losartan a “cost-effective intervention” for hypertension. Pharmacoecon. Outcomes News 493, 9 (2005). https://doi.org/10.2165/00151234-200504930-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504930-00018